Symmetry Investments’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,500	Closed	-$319K	–	124
2023 Q2	$319K	Buy	+3,500	New	+$319K	0.05%	110